[Federal Register Volume 61, Number 154 (Thursday, August 8, 1996)]
[Notices]
[Page 41427]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-20161]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 25, 1996, Allen, 
Dovensky & Company, Inc., 3529 Lincoln Highway, Thorndale, Pennsylvania 
19372, made application to the Drug Enforcement Administration (DEA) 
for registration as a bulk manufacturer of morphine (9300) a basic 
class of controlled substance listed in Schedule II.
    The firm plans to manufacture morphine for the purpose of deuterium 
labeled internal standards for distribution to analytical laboratories.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than October 7, 1996.
    Dated: July 31, 1996.

Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-20161 Filed 8-7-96; 8:45 am]
BILLING CODE 4410-09-M